OK Biotech Co Ltd

TPE:4155 (Taiwan)  
NT$ 25.50 (-0.39%) Jun 21
221.73
P/B:
1.55
Market Cap:
NT$ 3.75B ($ 115.75M)
Enterprise V:
NT$ 3.76B ($ 116.00M)
Volume:
222.02K
Avg Vol (2M):
963.26K
Trade In:
Volume:
222.02K
Avg Vol (2M):
963.26K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for OK Biotech Co Ltd ( ) from 2010 to Jun 22 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. OK Biotech stock (TPE:4155) PE ratio as of Jun 22 2024 is 221.73. More Details

OK Biotech Co Ltd (TPE:4155) PE Ratio (TTM) Chart

To

OK Biotech Co Ltd (TPE:4155) PE Ratio (TTM) Historical Data

Total 1221
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
OK Biotech PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-22 221.7 2024-04-18 208.7
2024-06-21 221.7 2024-04-17 208.7
2024-06-20 222.6 2024-04-16 206.1
2024-06-19 222.2 2024-04-15 210.9
2024-06-18 226.1 2024-04-12 216.1
2024-06-17 222.2 2024-04-11 217.0
2024-06-14 221.3 2024-04-10 212.2
2024-06-13 223.0 2024-04-09 210.9
2024-06-12 223.5 2024-04-08 212.2
2024-06-11 229.6 2024-04-03 211.7
2024-06-07 228.3 2024-04-02 213.0
2024-06-06 224.3 2024-04-01 213.9
2024-06-05 227.4 2024-03-29 214.3
2024-06-04 228.3 2024-03-28 209.1
2024-06-03 226.5 2024-03-27 966.0
2024-05-31 227.0 2024-03-26 960.0
2024-05-30 220.9 2024-03-25 966.0
2024-05-29 223.0 2024-03-22 960.0
2024-05-28 224.3 2024-03-21 960.0
2024-05-27 221.3 2024-03-20 964.0
2024-05-24 222.2 2024-03-19 968.0
2024-05-23 222.2 2024-03-18 970.0
2024-05-22 228.3 2024-03-15 966.0
2024-05-21 227.8 2024-03-14 964.0
2024-05-20 225.7 2024-03-13 974.0
2024-05-17 226.1 2024-03-12 994.0
2024-05-16 227.0 2024-03-11 984.0
2024-05-15 221.3 2024-03-08 962.0
2024-05-14 220.4 2024-03-07 976.0
2024-05-13 223.5 2024-03-06 982.0
2024-05-10 220.0 2024-03-05 984.0
2024-05-09 219.1 2024-03-04 984.0
2024-05-08 220.9 2024-03-01 994.0
2024-05-07 217.0 2024-02-29 NaN
2024-05-06 222.6 2024-02-27 990.0
2024-05-03 225.7 2024-02-26 998.0
2024-05-02 237.0 2024-02-23 998.0
2024-04-30 233.0 2024-02-22 NaN
2024-04-29 239.6 2024-02-21 NaN
2024-04-26 225.7 2024-02-20 NaN
2024-04-25 212.2 2024-02-19 NaN
2024-04-24 207.0 2024-02-16 998.0
2024-04-23 207.4 2024-02-15 998.0
2024-04-22 207.8 2024-02-09 NaN
2024-04-19 207.4 2024-02-08 NaN

OK Biotech Co Ltd (TPE:4155) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
OK Biotech Co Ltd is engaged in the manufacturing of electronic materials and medical equipment. The company's products include Portable Nebulizer, Blood Glucose Meter, Glucometer, Blood Sugar Meter, Blood Glucose Test Strips, and others. Geographically, the company generates a majority of its revenue from Asia (excluding Taiwan) followed by America, Africa, Europe, and Taiwan.